ロード中...
Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice
The combined glucose-lowering effect of exenatide and dapagliflozin has not yet been studied. We investigated this combination (single-dose or 4-week dosing) in diabetic ob/ob mice. Vehicle-corrected basal glucose showed greater reduction 1 h following exenatide + dapagliflozin than with exenatide o...
保存先:
| 出版年: | Diabetes Obes Metab |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237538/ https://ncbi.nlm.nih.gov/pubmed/24251534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12237 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|